35.16 USD
+0.04 (+0.11%)
35.16 USD
0 (0%)
BTSG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of BTSG get a neutral evaluation. Nothing too spectacular is happening here. BTSG is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
BTSG had positive earnings in the past year.
BTSG had a positive operating cash flow in the past year.
In multiple years BTSG reported negative net income over the last 5 years.
Of the past 5 years BTSG 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BTSG (2.14%) is comparable to the rest of the industry.
BTSG has a better Return On Equity (7.13%) than 67.33% of its industry peers.
The Return On Invested Capital of BTSG (4.68%) is comparable to the rest of the industry.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.22%.
The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.68%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROIC | 4.68% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
BTSG has a Profit Margin of 1.04%. This is comparable to the rest of the industry: BTSG outperforms 59.41% of its industry peers.
BTSG has a Operating Margin (2.15%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BTSG has grown nicely.
The Gross Margin of BTSG (12.30%) is worse than 70.30% of its industry peers.
In the last couple of years the Gross Margin of BTSG has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
BTSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BTSG has more shares outstanding
BTSG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BTSG has an improved debt to assets ratio.
2.2 Solvency
BTSG has an Altman-Z score of 3.31. This indicates that BTSG is financially healthy and has little risk of bankruptcy at the moment.
BTSG has a Altman-Z score of 3.31. This is in the better half of the industry: BTSG outperforms 72.28% of its industry peers.
The Debt to FCF ratio of BTSG is 9.17, which is on the high side as it means it would take BTSG, 9.17 years of fcf income to pay off all of its debts.
BTSG has a Debt to FCF ratio of 9.17. This is comparable to the rest of the industry: BTSG outperforms 48.51% of its industry peers.
A Debt/Equity ratio of 1.36 is on the high side and indicates that BTSG has dependencies on debt financing.
BTSG's Debt to Equity ratio of 1.36 is on the low side compared to the rest of the industry. BTSG is outperformed by 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Altman-Z | 3.31 |
ROIC/WACC0.53
WACC8.84%
2.3 Liquidity
A Current Ratio of 1.79 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG has a Current ratio of 1.79. This is in the better half of the industry: BTSG outperforms 69.31% of its industry peers.
A Quick Ratio of 1.38 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG has a Quick ratio (1.38) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
BTSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.02%, which is quite impressive.
Looking at the last year, BTSG shows a quite strong growth in Revenue. The Revenue has grown by 17.23% in the last year.
The Revenue has been growing by 20.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
3.2 Future
BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.45% yearly.
BTSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.41% yearly.
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y43.45%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y15.41%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 34.47 indicates a quite expensive valuation of BTSG.
BTSG's Price/Earnings ratio is in line with the industry average.
BTSG is valuated rather expensively when we compare the Price/Earnings ratio to 26.41, which is the current average of the S&P500 Index.
BTSG is valuated quite expensively with a Price/Forward Earnings ratio of 26.71.
The rest of the industry has a similar Price/Forward Earnings ratio as BTSG.
The average S&P500 Price/Forward Earnings ratio is at 35.40. BTSG is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.47 | ||
| Fwd PE | 26.71 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSG is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BTSG is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.97 | ||
| EV/EBITDA | 19.57 |
4.3 Compensation for Growth
BTSG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BTSG's earnings are expected to grow with 43.24% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y54.69%
EPS Next 3Y43.24%
5. Dividend
5.1 Amount
BTSG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
35.16
+0.04 (+0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners70.16%
Inst Owner Change3.27%
Ins Owners2.57%
Ins Owner Change-6.18%
Market Cap6.34B
Revenue(TTM)12.41B
Net Income(TTM)129.59M
Analysts84.21
Price Target40.21 (14.36%)
Short Float %7.71%
Short Ratio2.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.44%
PT rev (3m)37.3%
EPS NQ rev (1m)9.57%
EPS NQ rev (3m)12.68%
EPS NY rev (1m)-0.55%
EPS NY rev (3m)16.29%
Revenue NQ rev (1m)2.28%
Revenue NQ rev (3m)2.01%
Revenue NY rev (1m)1.31%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.47 | ||
| Fwd PE | 26.71 | ||
| P/S | 0.51 | ||
| P/FCF | 22.97 | ||
| P/OCF | 18.16 | ||
| P/B | 3.49 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.57 |
EPS(TTM)1.02
EY2.9%
EPS(NY)1.32
Fwd EY3.74%
FCF(TTM)1.53
FCFY4.35%
OCF(TTM)1.94
OCFY5.51%
SpS68.83
BVpS10.08
TBVpS-5.95
PEG (NY)0.4
PEG (5Y)N/A
Graham Number15.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROCE | 5.92% | ||
| ROIC | 4.68% | ||
| ROICexc | 4.83% | ||
| ROICexgc | 14.34% | ||
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% | ||
| FCFM | 2.22% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Debt/EBITDA | 5.55 | ||
| Cap/Depr | 40.71% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 1.44 | ||
| Cash Conversion | 78.31% | ||
| Profit Quality | 213.06% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.31 |
F-Score7
WACC8.84%
ROIC/WACC0.53
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y43.45%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y15.41%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year60.02%
EBIT Next 3Y26.18%
EBIT Next 5Y28.14%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%
BRIGHTSPRING HEALTH SERVICES / BTSG FAQ
Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?
ChartMill assigns a fundamental rating of 4 / 10 to BTSG.
What is the valuation status for BTSG stock?
ChartMill assigns a valuation rating of 4 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Fairly Valued.
How profitable is BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.
What is the expected EPS growth for BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 85.44% in the next year.